part Part I: Pseudomonas exotoxin-based immunotoxins/cytotoxins -- chapter 1 Targeting of Pseudomonas exotoxin-based immunotoxins to hematologic malignancies -- chapter 2 Interleukin-4-targeted cytotoxin for recurrent glioblastoma therapy -- chapter 3 Interleukin-13 receptors and development of IL-13-Pseudomonas exotoxin for human cancer therapy -- part Part II: Ricin-based immunotoxins/cytotoxins -- chapter 4 Ricin immunotoxins in lymphomas: Clinical application -- part Part III: Diphtheria toxin-based immunotoxins/cytotoxins -- chapter 5 Diphtheria-based immunotoxins: Targeting overexpressed interleukin-13 receptor and urokinase-type plasminogen activator receptor on glioblastoma multiforme -- chapter 6 DAB389IL-2 (Ontak�): Development and therapeutic applications -- chapter 7 Transferrin diphtheria toxin for brain tumor therapy -- chapter 8 GM-CSF receptor-targeted therapy of human leukemia -- chapter 9 VEGF-Diphtheria toxin for targeting tumor blood vessels -- part Part IV: Miscellaneous -- chapter 10 cBR96-Doxorubicin (SGN-15) for metastatic breast cancer therapy -- chapter 11 Anti-CD33 calicheamicin immunoconjugate therapy of acute myeloid leukemia.